Physician profile
Stephen Lee Ryder
NPI 1821344771
$466.87
in general payments reported to CMS, 2019-2025
9 companies · $17.68 in 2025
The $17.68 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.45 · 2022: $13.79 · 2023: $66.86 · 2024: $309 · 2025: $17.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $229.61 | 2024 | Xiaflex |
| Heron Therapeutics, INC. | $57.09 | 2024 | Zynrelef |
| Vericel Corporation | $40.07 | 2024-2025 | Maci |
| Depuy Synthes Sales INC. | $40.04 | 2021-2023 | Orthovisc, Monovisc |
| Horizon Therapeutics Plc | $28.81 | 2021-2022 | |
| Pacira Therapeutics, INC. | $21.14 | 2021 | |
| Atricure, INC. | $20.00 | 2023 | |
| Ferring Pharmaceuticals INC. | $16.38 | 2023 | Euflexxa |
| Molnlycke Health Care US, LLC | $13.73 | 2023 | Mepilex Border Post-Op Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Ryder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.